Search Results - "Sleeper, Meg M"

Refine Results
  1. 1

    The aorta in humans and African great apes, and cardiac output and metabolic levels in human evolution by Ríos, Luis, Sleeper, Meg M., Danforth, Marietta D., Murphy, Hayley Weston, Kutinsky, Ilana, Rosas, Antonio, Bastir, Markus, Gómez-Cambronero, José, Sanjurjo, Ricardo, Campens, Laurence, Rider, Oliver, Pastor, Francisco

    Published in Scientific reports (26-04-2023)
    “…Humans have a larger energy budget than great apes, allowing the combination of the metabolically expensive traits that define our life history. This budget is…”
    Get full text
    Journal Article
  2. 2

    Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat by Bish, Lawrence T, Morine, Kevin, Sleeper, Meg M, Sanmiguel, Julio, Wu, Di, Gao, Guangping, Wilson, James M, Sweeney, H Lee

    Published in Human gene therapy (01-12-2008)
    “…Heart disease is the leading cause of morbidity and mortality. Cardiac gene transfer may serve as a novel therapeutic approach. This investigation was…”
    Get more information
    Journal Article
  3. 3

    Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse by Selsby, Joshua T, Acosta, Pedro, Sleeper, Meg M, Barton, Elisabeth R, Sweeney, H Lee

    Published in Journal of applied physiology (1985) (01-09-2013)
    “…Dystrophin-deficient muscles suffer from free radical injury, mitochondrial dysfunction, apoptosis, and inflammation, among other pathologies that contribute…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice by Morine, Kevin J, Bish, Lawrence T, Pendrak, Klara, Sleeper, Meg M, Barton, Elisabeth R, Sweeney, H Lee

    Published in PloS one (11-02-2010)
    “…Myostatin inhibition is a promising therapeutic strategy to maintain muscle mass in a variety of disorders, including the muscular dystrophies, cachexia, and…”
    Get full text
    Journal Article
  6. 6

    Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice by Bish, Lawrence T, Yarchoan, Mark, Sleeper, Meg M, Gazzara, Jeffrey A, Morine, Kevin J, Acosta, Pedro, Barton, Elisabeth R, Sweeney, H Lee

    Published in PloS one (22-06-2011)
    “…Duchenne muscular dystrophy (DMD) is a degenerative disorder affecting skeletal and cardiac muscle for which there is no effective therapy. Angiotension…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model by Bish, Lawrence T, Morine, Kevin J, Sleeper, Meg M, Sweeney, H Lee

    Published in PloS one (19-04-2010)
    “…Myostatin is well established as a negative regulator of skeletal muscle growth, but its role in the heart is controversial. Our goal in this study was to…”
    Get full text
    Journal Article
  9. 9

    Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of duchenne muscular dystrophy by Morine, Kevin J., Bish, Lawrence T., Selsby, Joshua T., Gazzara, Jeffery A., Pendrak, Klara, Sleeper, Meg M., Barton, Elisabeth R., Lee, Se-Jin, Sweeney, H. Lee

    Published in Muscle & nerve (01-11-2010)
    “…Modulation of transforming growth factor‐β (TGF‐β) signaling to promote muscle growth holds tremendous promise for the muscular dystrophies and other disorders…”
    Get full text
    Journal Article
  10. 10

    Transendocardial delivery of AAV6 results in highly efficient and global cardiac gene transfer in rhesus macaques by Gao, Guangping, Bish, Lawrence T, Sleeper, Meg M, Mu, Xin, Sun, Lan, Lou, You, Duan, Jiachuan, Hu, Chunyan, Wang, Li, Sweeney, H Lee

    Published in Human gene therapy (01-08-2011)
    “…Heart disease is the leading cause of morbidity and mortality, and cardiac gene transfer has potential as a novel therapeutic approach. We previously…”
    Get more information
    Journal Article
  11. 11

    Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage by Morine, Kevin J, Sleeper, Meg M, Barton, Elisabeth R, Sweeney, H Lee

    Published in Human gene therapy (01-12-2010)
    “…Although the precise pathophysiological mechanism of muscle damage in dystrophin-deficient muscle remains disputed, calcium appears to be a critical mediator…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs by Bigg, Paul W., Baldo, Guilherme, Sleeper, Meg M., O'Donnell, Patricia A., Bai, Hanqing, Rokkam, Venkata R.P., Liu, Yuli, Wu, Susan, Giugliani, Roberto, Casal, Margret L., Haskins, Mark E., Ponder, Katherine P.

    Published in Molecular genetics and metabolism (01-11-2013)
    “…Mucopolysaccharidosis VII (MPS VII) is due to the deficient activity of β-glucuronidase (GUSB) and results in the accumulation of glycosaminoglycans (GAGs) in…”
    Get full text
    Journal Article
  14. 14

    Canine bacterial endocarditis: a review by Peddle, Gordon, Sleeper, Meg M

    “…Bacterial endocarditis is a disease of primarily middle-aged to older, large-breed dogs that is associated with high morbidity and mortality. It presents many…”
    Get more information
    Journal Article
  15. 15

    Sudden cardiac death in 13 captive chimpanzees (Pan troglodytes) by Lammey, Michael L, Lee, D. Rick, Ely, John J, Sleeper, Meg M

    Published in Journal of medical primatology (01-02-2008)
    “…Sudden cardiac death (SCD), presumed secondary to fatal arrhythmias, is a common cause of mortality in captive chimpanzees at the Alamogordo Primate Facility…”
    Get full text
    Journal Article
  16. 16

    Status of Therapeutic Gene Transfer to Treat Cardiovascular Disease in Dogs and Cats by Sleeper, Meg M

    “…Gene therapy is a procedure resulting in the transfer of a gene into an individual's cells to treat a disease. One goal of gene transfer is to express a…”
    Get more information
    Journal Article
  17. 17

    Equine Cardiovascular Therapeutics by Sleeper, Meg M

    “…Heart disease can be defined as any abnormality of the heart whether it is a cardiac dysrhythmia or structural heart disease, either congenital or acquired…”
    Get more information
    Journal Article
  18. 18

    Monitoring great ape heart health through innovative electrocardiogram technology: Training methodologies and welfare implications by Cloutier Barbour, Christina, Danforth, Marietta D., Murphy, Hayley, Sleeper, Meg M., Kutinsky, Ilana

    Published in Zoo biology (01-11-2020)
    “…Assessing and treating cardiovascular disease (or heart disease) is a growing concern for institutions housing great apes, as it is a major cause of mortality…”
    Get full text
    Journal Article
  19. 19

    Pharmacokinetics of furosemide after intravenous, oral and transdermal administration to cats by Sleeper, Meg M, O’Donnell, Patricia, Fitzgerald, Caitlin, Papich, Mark G

    Published in Journal of feline medicine and surgery (01-10-2019)
    “…Objectives The aim of this study was to determine the pharmacokinetics of furosemide in cats following intravenous (IV), oral and transdermal administration…”
    Get full text
    Journal Article
  20. 20

    Use of the vertebral heart scale for differentiation of cardiac and noncardiac causes of respiratory distress in cats: 67 cases (2002–2003) by Sleeper, Meg M, Roland, Risa, Drobatz, Kenneth J

    “…Objective-To assess the effectiveness of the vertebral heart scale (VHS) system to differentiate congestive heart failure from other causes of dyspnea in cats…”
    Get full text
    Journal Article